MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Umbralisib hydrochloride

CAS No. : 1532533⁻⁷8-0

MCE 国际站：Umbralisib hydrochloride

产品活性：Umbralisib hydrochloride (TGR-1202 hydrochloride) 是一种新颖的 PI3Kδ 抑制剂，IC₅₀ 和 EC₅₀ 值分别为 22.2 nM 和 24.3 nM；Umbralisib hydrochloride (TGR-1202 hydrochloride) 同时可抑制 CK1ε，EC₅₀ 值为 6.0 μM。

研究领域：PI3K/Akt/mTOR

作用靶点：PI3K

In Vitro: Umbralisib (RP5264) causes a half-maximal inhibition of human whole blood CD19 cell proliferation between 100-300 nM. In human lymphoma ａnd leukemia cell lines, Umbralisib (TGR-1202; 10 nM-100 μM) inhibits phosphorylated AKT at Ser473 in a concentration-dependent manner. Umbralisib ａnd carfilzomib synergistically kill blood cancer cells through disrupting the 4E-BP1-eIF4F-c-Myc axis. Umbralisib ａnd carfilzomib in combination synergistically ａnd selectively silence the c-Myc ａnd E2F transcription programs. Umbralisib (15-50 μM) potently represses the expression of c-Myc in the DLBCL cell line LY7, ａnd is uniquely characterized with structural features suitable for targeting CK1ε in lymphoma cells.

In Vivo: In a subcutaneous xenograft model of T-cell acute lymphoblastic leukemia (T-ALL) in NOD/SCID mice using the MOLT-4 cell line, Umbralisib (TGR-1202; 150 mg/kg, daily p.o.) significantly shrinks the tumors by day 25.

相关产品：Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Kinase Inhibitor Library | PI3K/Akt/mTOR Compound Library | Stem Cell Signaling Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Differentiation Inducing Compound Library | Oxygen Sensing Compound Library | Glycolysis Compound Library | Cytoskeleton Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | 3-Methyladenine | LY294002 | Wortmannin | Quercetin | 740 Y-P | PI-103 | Isorhamnetin | Recilisib | Autophinib | PI3K-IN-1 | TG100-115 | 1-Deoxynojirimycin | AZD 6482 | AS-605240 | TGX-221 | YS-49 | α-Linolenic acid | Disitertide | PKI-402 | Erucic acid | GSK1059615 | Sonolisib | HS-173 | 1,3-Dicaffeoylquinic acid | CNX-1351 | GNE-317 | Esculetin | Oroxin B | Acalisib

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。